Society for Cardiovascular Angiography & Interventions SHOCK 2025

25 $

+ Include:  videos + pptx, size:  GB

+ Target Audience: Interventional Cardiologists, Critical Care Cardiologists, Cardiac Surgeons, Intensivists, and Advanced Practice Providers (APPs)

Description

+ Include:  videos + pptx, size:  GB

+ Target Audience: Interventional Cardiologists, Critical Care Cardiologists, Cardiac Surgeons, Intensivists, and Advanced Practice Providers (APPs)

+ Sample video: contact me for sample video

+ Information:

The 2025 SCAI SHOCK: Home of the Shock Team conference, scheduled for September 18–20, 2025, in Tampa, Florida, is a step-by-step guide to building and maintaining a contemporary cardiogenic shock program. Led by a multidisciplinary team of seasoned leaders, the meeting explores the individual building blocks of a successful shock program, equipping attendees with a comprehensive understanding of shock management, from initial recognition and ICU problem-solving to advanced treatment strategies and post-danger care.

Learning Objectives

This year’s meeting will equip attendees to:

  • Integrate scientific updates and the latest evidence-based best practices for treating cardiogenic shock and cardiac arrest.

  • Implement optimal shock management strategies by utilizing EMS, transportation, and the ED in early recognition and nuanced patient care.

  • Apply Shock ICU essentials, including hemodynamic monitoring, vasoactive medications, and determining the role of dedicated versus mixed ICUs.

  • Optimize antiplatelet therapy and implement optimal pharmacodynamic strategies for high-risk patients.

  • Navigate complexities in the cath lab by identifying unseen threats, understanding right heart hemodynamics, and practicing effective communication.

  • Optimize team setup, tracking quality improvement metrics, and utilizing tools to bridge the gap between shock clinicians and hospital administration (the C-suite).

  • Perform Cardiac ICU problem-solving, including interpreting cardiac indices, troubleshooting MCS devices, and managing weaning strategies.

  • Manage post-danger care by deliberating the harms and benefits of inotropes, utilizing IABP in the community, and expanding perspectives to include HF-shock.

  • Navigate the complexities of resource allocation and coordination for High-risk PCI.

  • Explore future directions in shock management, including novel support devices, leveraging machine learning for risk stratification, and the role of AI in decision-making.

Target Audience

Translating the ideal to the real world will be intensivists (medical/cardiac), cardiologists (interventional, heart failure, critical care), cardiac surgeons, advanced practice providers (APPs), and hospital administrators representing the diversity of clinical practice settings to help you apply what you learn in:

  • Community and academic hospitals

  • Urban and rural locations

  • Surgical and non-surgical settings

  • Treating patients with and without advanced heart failure

Suitable for representatives of hospitals looking to improve or formalize their shock program, including but not limited to cardiologists, intensivists, surgeons, nurses, APPs, and hospital administrators within the disciplines of critical care, cardiothoracic surgery, heart failure, interventional cardiology, and CV service line leadership.

Best for Interventional Cardiologists, Critical Care Cardiologists, Cardiac Surgeons, Intensivists, and Advanced Practice Providers (APPs).

Topics

Below is the comprehensive and detailed list of topics and sessions covered during the conference:

Breakfast Session: Mapping the Maze of Cardiogenic Shock – Shock Phenotypes, Stages, and Hemodynamics

  • SCAI DLC Initiative Definition, Hypothesis and Call to Action

  • One Shock Doesn’t Fit All – Cardiogenic Shock Phenotypes

  • IABP Inflated Hopes or Deflated Use SCAI Staging and Cardiogenic Shock Controversies in Clinical Trials

  • Shocking Developments Hemodynamics & Treatment in CS

Breakfast Satellite: Complex PCI – Nothing Is Simple in Shock Patients!

  • Introductory Remarks

  • CTO’s in AMI-Shock – When and How to Treat

  • What is Complex and High Risk – Patient Population and Tools/Skillsets Needed to Treat

  • Getting In and Out Safely – Vascular Access and Closure in AMI-CS

  • Keeping Your Eyes Open – Role of Intravascular Imaging in Complex PCI

  • To Support or Not to Support – MCS in AMI-Shock

  • Chipping Away – Calcium Modification in Complex PCI

Lunch Satellite: Management of Shock in Patients With Pulmonary Embolism (CME)

  • Introductory Remarks

  • Mechanical Circulatory Support in Pulmonary Embolism

  • Normotensive Does Not Mean Low Risk Insights from the FLASH Registry

  • Questions Remaining Unanswered in Published Thrombectomy Trials, Where Do We Go from Here

  • What Role does a Surgeon Have on the PERT Team

  • Choosing the Right Treatment for the Right PE Patient

Lunch Program: Optimizing Antiplatelet Therapy in Cardiogenic Shock

  • Introductory Remarks and Polling Questions

  • Pharmacodynamics of Antiplatelet Therapies With and Without CS

  • Optimal Antiplatelet Strategies in High-risk Patients

  • Data for use of Cangrelor in AMI-CS and High-Risk PCI

  • Case Presentation and Initial Clinical Course

  • Case Continuation and Conclusion

  • Concluding Remarks and Polling Questions

Dinner Program: ECMO Workshop – When and How to Use a Powerful Tool

  • Introductory Remarks

  • Tips for Safe Cannulation

  • Venoarterial ECMO Indications

Systems of Care in Cardiogenic Shock Teams, Networks and Post Discharge Management

  • Shock Survivorship The Role of Cardiogenic Shock Clinics Post-Hospital Discharge

  • When to Call the Shock Team Protocol Dissemination in the Community

  • Time is Tissue EMS and ED Protocols for the Shock Patient

  • CS Management in 2025 Optimizing CICU Staffing Models

  • From Shock Teams to Shock Networks The Hub and Spoke Model

Managing Cardiogenic Shock in Patients with Valvular Heart Disease

  • At the Intersection of Valvular Disease and Cardiogenic Shock – Common Clinical Scenarios and Contemporary Outcomes

  • CASE 1 Critical AS and Cardiogenic Shock

  • CASE 2 Emergent M-TEER for Severe MR and Cardiogenic Shock

Top & Challenging Shock Cases

  • Regurgitation, Reperfusion, Rescue ECMO in the Setting of Aortic Valve Catastrophe

  • Cardiac Arrest During Acute MI Revascularization Mobile VA-ECMO and Progressive Mechanical Support Enable Survival

  • VA-ECMO as a Bridge to Transplant Following Apical Wall Rupture

  • Escalation and De-escalation CASE HF-CS

  • Escalation and De-escalation CASE AMI Shock with Escalation to Impella 5.5

Breakout Session – The People’s Ventricle: Right Ventricular Cardiogenic Shock

  • CICU Management of RV-Predominant Cardiogenic Shock

  • Epidemiology and Initial Medical Management of RV Shock

  • RV Shock Due to CTEPH BPA vs. Surgery

  • MCS for Treatment of RV-Predominant Cardiogenic Shock

Breakout Session – The Shock Coordinator Playbook: Practical Strategies for Optimal Care

  • Shock Tracking Harnessing the Right Tools for Better Outcomes

  • Shock Coordinators 101 Navigating the Frontlines of Cardiogenic Shock Care

  • Shock Case Review Turning Data into Impactful Care

  • Building a Shock Network Connecting Care Inside and Out

Breakout Session – This Job is Stressful! Maintaining Your Own Wellbeing

  • Dealing with Complications and Unexpected Outcomes

  • The Second Victim Syndrome

  • Don’t Suffer in Silence Finding a Support Network

  • Can I Prevent Moral Injury and Compassion Fatigue

Breakout Session – The Advanced Practitioner’s Role in the Critical Care Unit

  • Investing in APPs in the ICU

  • Benefits of Having APPs in the ICU From a Surgeon/HF Attending Perspective

  • Discussion

  • Expanding Into an MCS APP Team

  • How to Utilize APPs in an ICU

Getting Your Hospital Administrators on Your Team

  • Physician Compensation Models RVUs and Shock Call

  • Optimizing Hub and Spoke Model The Financial Benefits of a Shock Program

  • How to get Support From the C-Suite

  • Finances of ECMO

Reviews

There are no reviews yet.

Be the first to review “Society for Cardiovascular Angiography & Interventions SHOCK 2025”

Your email address will not be published. Required fields are marked *

ten × one =
Powered by MathCaptcha